Clinical Trial Update: Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating photodynamic therapy with verteporfin for chronic central serous chorioretinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Visudyne (verteporfin)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Chronic Central Serous Chorioretinopathy | Phase 2 | Status: COMPLETED